β-defensin 123 inhibitors are a class of compounds that specifically target and regulate the activity of β-defensin 123, a small, cationic peptide belonging to the larger family of defensins. Defensins, including β-defensin 123, are known for their role in modulating various biochemical pathways, particularly those involving innate immune responses in multicellular organisms. Structurally, β-defensin 123 is characterized by its conserved β-sheet fold stabilized by disulfide bridges, which are integral to its function. The inhibitors of this peptide typically interact with its key surface residues or the metal ion coordination sites, thereby modulating its biological activity. These inhibitors often employ mechanisms such as direct binding to the peptide, allosteric inhibition, or competitive interactions that block its interactions with other biomolecules or ion channels. Through such interactions, β-defensin 123 inhibitors can effectively reduce or modulate the peptide's capacity to engage in signal transduction processes that are crucial for maintaining cellular homeostasis.
Chemically, β-defensin 123 inhibitors encompass a broad spectrum of molecules, ranging from small organic compounds to larger macromolecular structures like peptides and proteins. The molecular diversity within this class allows for a variety of inhibition mechanisms, including non-covalent interactions like hydrogen bonding, van der Waals forces, and hydrophobic effects. In some cases, metal chelation is also employed to disrupt the structural stability of β-defensin 123, further diminishing its functional role in cellular systems. The design and synthesis of β-defensin 123 inhibitors often involve considerations of molecular docking studies and high-throughput screening techniques to identify potential binding sites and optimize inhibitory efficacy. These compounds provide a valuable tool for studying the biochemical pathways and structural features of defensins and their broader implications in molecular biology and cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A glucocorticoid that can suppress inflammation and consequently might downregulate defensins, which are often upregulated during inflammatory responses. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A compound that modulates NF-κB activity; since NF-κB is a transcription factor that can regulate defensin expression, curcumin may reduce their levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor; by inhibiting mTOR, it can suppress the immune response, potentially decreasing defensin expression. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressant that may downregulate defensin expression by inhibiting T-cell activation. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
A corticosteroid that can suppress inflammation and may decrease expression of defensins involved in immune responses. | ||||||
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Acetylsalicylic acid inhibits COX enzymes and may reduce defensin expression by suppressing inflammatory pathways. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
An immunosuppressive agent that may diminish defensin expression by inhibiting lymphocyte proliferation. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
An immunosuppressive drug; it can downregulate the immune response and potentially defensin expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
A dihydrofolate reductase inhibitor, which may result in reduced immune function and thus lower defensin levels. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
An immunosuppressant that may reduce defensin expression by inhibiting T-cell activation and IL-2 transcription. | ||||||